Cyclerion Therapeutics (CYCN) Assets Average (2019 - 2025)
Cyclerion Therapeutics (CYCN) has disclosed Assets Average for 7 consecutive years, with $9.9 million as the latest value for Q3 2025.
- For Q3 2025, Assets Average rose 4.33% year-over-year to $9.9 million; the TTM value through Sep 2025 reached $9.9 million, up 4.33%, while the annual FY2024 figure was $11.5 million, 27.04% down from the prior year.
- Assets Average hit $9.9 million in Q3 2025 for Cyclerion Therapeutics, up from $9.6 million in the prior quarter.
- Across five years, Assets Average topped out at $107.7 million in Q1 2021 and bottomed at $9.2 million in Q4 2024.
- Average Assets Average over 5 years is $31.6 million, with a median of $14.3 million recorded in 2023.
- Year-over-year, Assets Average crashed 73.63% in 2023 and then grew 4.33% in 2025.
- Cyclerion Therapeutics' Assets Average stood at $63.5 million in 2021, then plummeted by 66.06% to $21.6 million in 2022, then tumbled by 33.72% to $14.3 million in 2023, then tumbled by 35.38% to $9.2 million in 2024, then increased by 7.1% to $9.9 million in 2025.
- According to Business Quant data, Assets Average over the past three periods came in at $9.9 million, $9.6 million, and $9.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.